Cite
MLA Citation
Claudia Cardone et al.. “Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer.” ESMO open, vol. 4, no. 4, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100127565157.0x00001b